These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8239562)

  • 41. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Muscle histopathology in myotonic dystrophy in relation to age and muscular weakness.
    Tohgi H; Kawamorita A; Utsugisawa K; Yamagata M; Sano M
    Muscle Nerve; 1994 Sep; 17(9):1037-43. PubMed ID: 8065390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exchange of 3-methylhistidine in the splanchnic region in human infection.
    Sjölin J; Stjernström H; Arturson G; Andersson E; Friman G; Larsson J
    Am J Clin Nutr; 1989 Dec; 50(6):1407-14. PubMed ID: 2596430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myotonic dystrophy with no trinucleotide repeat expansion.
    Thornton CA; Griggs RC; Moxley RT
    Ann Neurol; 1994 Mar; 35(3):269-72. PubMed ID: 8122879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [ON THE RELATION OF MYOTONIC DYSTROPHY TO ATROPHY OF THE PERENEAL MUSCLE].
    WALD I; LOESCH D; WOCHNIK D
    Neurol Neurochir Psychiatr Pol; 1963; 13():27-33. PubMed ID: 14043234
    [No Abstract]   [Full Text] [Related]  

  • 46. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
    Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of prednisone on protein metabolism in Duchenne dystrophy.
    Rifai Z; Welle S; Moxley RT; Lorenson M; Griggs RC
    Am J Physiol; 1995 Jan; 268(1 Pt 1):E67-74. PubMed ID: 7840185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The changes in muscle strength and relaxation time after a comprehensive rehabilitation program for patients with myotonic dystrophy.
    Moon JH; Na YM; Kang SW; Lee HS
    Yonsei Med J; 1996 Aug; 37(4):237-42. PubMed ID: 8942293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Excretion of total and muscular N tau-methylhistidine and creatinine in muscle diseases.
    Röthig HJ; Bernhardt W; Afting EG
    Muscle Nerve; 1984 Jun; 7(5):374-9. PubMed ID: 6738575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy.
    Johansson A ; Andrew R; Forsberg H; Cederquist K; Walker BR; Olsson T
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4276-83. PubMed ID: 11549662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rates of muscle protein breakdown in chickens selected for increased growth rate, food consumption or efficiency of food utilisation as assessed by N tau-methylhistidine excretion.
    Tomas FM; Jones LM; Pym RA
    Br Poult Sci; 1988 Jun; 29(2):359-70. PubMed ID: 3409081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress.
    Koutsoulidou A; Kyriakides TC; Papadimas GK; Christou Y; Kararizou E; Papanicolaou EZ; Phylactou LA
    PLoS One; 2015; 10(4):e0125341. PubMed ID: 25915631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered body composition and muscle protein degradation in nutritionally growth-retarded children with cystic fibrosis.
    Miller M; Ward L; Thomas BJ; Cooksley WG; Shepherd RW
    Am J Clin Nutr; 1982 Sep; 36(3):492-9. PubMed ID: 7113955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy--a clinical research center study.
    Vlachopapadopoulou E; Zachwieja JJ; Gertner JM; Manzione D; Bier DM; Matthews DE; Slonim AE
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3715-23. PubMed ID: 8530624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doppler echocardiographic assessment of left ventricular diastolic function in myotonic dystrophy.
    Fragola PV; Caló L; Luzi M; Mammarella A; Antonini G
    Cardiology; 1997; 88(6):498-502. PubMed ID: 9397301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myotonic dystrophy.
    Jozefowicz RF; Griggs RC
    Neurol Clin; 1988 Aug; 6(3):455-72. PubMed ID: 3065594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breathing pattern awake and asleep in patients with myotonic dystrophy.
    Veale D; Cooper BG; Gilmartin JJ; Walls TJ; Griffith CJ; Gibson GJ
    Eur Respir J; 1995 May; 8(5):815-8. PubMed ID: 7656955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sonographic similarities of inclusion body myositis and myotonic dystrophy.
    Karvelas KR; Hommel AL; Cartwright MS; Walker FO; Hobson-Webb LD
    Muscle Nerve; 2018 Oct; 58(4):E25-E26. PubMed ID: 30028511
    [No Abstract]   [Full Text] [Related]  

  • 59. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes.
    Thornton CA; Johnson K; Moxley RT
    Ann Neurol; 1994 Jan; 35(1):104-7. PubMed ID: 8285579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bite force and handgrip force in patients with molecular diagnosis of myotonic dystrophy.
    Guimaraes AS; Carlsson GE; Marie SK
    J Oral Rehabil; 2007 Mar; 34(3):195-200. PubMed ID: 17302947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.